BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2570808)

  • 1. [Evaluation of sialyl SSEA-1 antigen in patients with lung cancer].
    Shiota T; Matsubara Y; Ikeda S; Ishida H; Katsura A; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T
    Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1067-73. PubMed ID: 2570808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of carbohydrate antigens--sialylated Lewisx and sialylated SSEA-1 in the sera from patients with primary lung cancer].
    Mukae H; Hirota M; Morikawa N; Oda H; Sakito O; Shikuwa T; Senju R; Fukushima K; Hiratani K; Kadota J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):881-6. PubMed ID: 2575681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of serum CA130 in patients with lung cancer].
    Matsubara Y; Shiota T; Ishida H; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T; Ikeda S
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1557-65. PubMed ID: 2572655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
    Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
    Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
    Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
    Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of CA-50, SLX and ST-439 in lung cancer].
    Hayasaka S; Takada M; Shinohara T; Imamura S; Takifuji N; Kudoh S; Matsui K; Kusunoki Y; Masuda N; Negoro S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):802-7. PubMed ID: 1681128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialyl stage-specific embryonic antigen levels in adenocarcinoma of the lung.
    Lee YC; Yang MH; Huang MH; Lai SL; Perng RP
    J Formos Med Assoc; 1992 Aug; 91(8):760-3. PubMed ID: 1362113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 2. Evaluation of clinical significance].
    Imura H; Endo J; Ohkura H; Ishii M; Ariyoshi Y; Abe O; Masamune O; Nishimoto Y; Fukushi Y; Orikasa S
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1322-31. PubMed ID: 2883937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
    Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
    Kobayashi H; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of ovarian cancer, benign ovarian tumor and endometriosis by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels.
    Iwanari O; Miyako J; Date Y; Nakayama S; Kijima S; Moriyama M; Takahashi K; Yoshino N; Karino K; Endoh J
    Gynecol Obstet Invest; 1990; 29(1):71-4. PubMed ID: 1972127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
    Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
    Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantage of cocktail-use of two anti-tumor monoclonal antibodies, KM-93 and KM-231, in serum diagnosis of cancer.
    Shitara K; Hanai N; Furuya A; Yoshida H
    Anticancer Res; 1989; 9(4):999-1004. PubMed ID: 2479331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients].
    Tanaka T; Iwasaka T; Hayashi Y; Hachisuga T; Yokoyama M; Ohkuma Y; Matsuo N; Fukuda K; Sugimori H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1157-61. PubMed ID: 1975831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
    Shitara K; Hanai N; Yoshida H
    Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sialyl Lewis(x)-I (SLX) as a tumor-associated carbohydrate antigen in sera in patients with gastric and colorectal cancer--evaluation according to clinico-pathological factors].
    Nakagoe T; Ishikawa H; Nakao H; Satoh T; Miyashita K; Yokota M; Takahira R; Kusano H; Shimizu T; Fukuda Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):819-25. PubMed ID: 2565704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
    Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
    J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.